BiondVax Pharmaceuticals Ltd. (BVXV) Cash Flow Annual - Discounting Cash Flows
BVXV
BiondVax Pharmaceuticals Ltd.
BVXV (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
2013
12-31
2012
12-31
2011
12-31
Report Filing: 2023-08-11 2023-04-17 2022-03-28 2021-05-13 2020-06-12 2019-04-30 2018-04-30 2017-04-28 2016-04-27 2014-12-31 2013-12-31 2012-12-31 2011-12-31
Net Income/Starting Line 19.58 -5.8 -39.98 -4.46 -109.2 -87.73 -34.55 -9.18 -10.2 -7.76 -8.04 -9.33 -7.72
Cash From Operating Activities 9.92 -7.26 -24.48 -72.54 -77.06 -57.19 -10.05 -9.65 -10.27 -7.57 -4.21 -7 -9.67
Depreciation and Amortization -1.14 0.562 2.42 2.44 1.65 0.26 0.44 0.621 0.628 0.677 0.709 0.731 0.6
Deferred Income Tax -0.765 0 -0.033 -0.037 -0.122 0.051 -0.053 0.042 0.002 0.059 0.14 0.237 0.451
Stock Based Compensation 0.452 1.6 8.9 9.47 3.68 0.26 0.519 1.26 0.745 0.363 0.562 0.516 0.56
Other Non-Cash Items 0.009 -3.9 -0.97 12.78 15.9 -1.46 21.14 -2.67 -1.1 -0.319 0.535 0.434 -0.057
Changes in Working Capital -3.65 0.271 5.18 -92.73 11.03 31.42 2.4 0.323 -0.339 -0.529 2.02 0.645 -3.06
Accounts Receivable 0 0 0 0 0 0 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0
Accounts Payable 1.54 -0.175 1.24 -15.19 -3.66 14.5 5.54 -0.238 0.415 0.132 -0.012 -0.741 -0.802
Deferred Revenue -5.19 0.446 3.94 -77.54 14.69 16.92 -3.14 0.561 -0.754 -0.661 2.04 1.39 -2.25
Other Working Capital 0 0 0 0 0 0 0 0 0 0 0 0 0
Cash From Investing Activities -0.866 -0.836 -0.361 -5.93 -7.2 -23.45 6.76 -7.81 -0.043 -0.18 2.02 -0.419 -2.78
Investments in Property Plant and Equipment -0.873 -0.836 -0.43 -6.13 -7.43 -23.73 -4.51 -0.02 -0.034 -0.03 -0.196 -0.309 -2.73
Payments for Acquisitions 0 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Securities 0 0 0 0 0 0 0 0 0 0 0 0 0
Sales and Maturities of Investments 0 0 0 0 0 0 4.07 0 0 0 2.08 0 0
Other Investing Activities 0.007 0 0.069 0.197 0.23 0.277 7.2 -7.79 -0.009 -0.15 0.141 -0.11 -0.05
Cash From Financing Activities -25.81 6.78 67.78 13.72 85.21 84.32 61.84 0 33.75 -0.782 9.25 4.94 4.74
Debt Repayment 0 0 0 0 0 0 0 0 0 0 0 0 0
Common Stock Issued -27.55 0.932 69 0 70.27 0 55.69 0 27.32 0 9.25 4.8 4.75
Common Stock Repurchased 0.681 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities -25.81 6.78 67.78 13.72 85.21 84.32 61.84 0 33.75 -0.782 9.25 4.94 4.74
Effect of Forex Changes on Cash -2.69 -1.98 1.68 1.71 -4.37 0.827 -2.87 -0.299 0.415 0.283 -0.233 -0.071 0.105
Net Change in Cash -31.87 -3.3 44.62 -63.05 -3.42 4.5 55.68 -17.77 23.86 -8.25 6.83 -2.56 -7.61
Cash at Beginning of Period 39.5 17.52 9.42 72.47 75.88 71.38 15.71 33.47 9.61 17.86 11.03 13.59 21.2
Cash at End of Period 7.63 14.21 54.04 9.42 72.47 75.88 71.38 15.71 33.47 9.61 17.86 11.03 13.59
Free Cash Flow 9.04 -8.1 -24.91 -78.67 -84.49 -80.92 -14.56 -9.67 -10.3 -7.6 -4.4 -7.31 -12.4
Operating Cash Flow 9.92 -7.26 -24.48 -72.54 -77.06 -57.19 -10.05 -9.65 -10.27 -7.57 -4.21 -7 -9.67
Capital Expenditure -0.873 -0.836 -0.43 -6.13 -7.43 -23.73 -4.51 -0.02 -0.034 -0.03 -0.196 -0.309 -2.73
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us